Skip to main content
A

Ananda Pharma Plc — Investor Relations & Filings

Ticker · ANAN ISIN · GB00BDQPXQ60 LEI · 894500DFM8VOC5FW4X47 Aquis Stock Exchange Manufacturing
Filings indexed 196 across all filing types
Latest filing 2021-07-16 Share Issue/Capital Cha…
Country GB United Kingdom
Listing Aquis Stock Exchange ANAN

About Ananda Pharma Plc

https://www.anandapharma.co.uk/

Ananda Pharma Plc is a biopharmaceutical company focused on the development of regulatory-approved, cannabinoid-based medicines. The company's primary mission is to create therapies for complex, chronic inflammatory conditions with significant unmet medical needs. Its development pipeline is initially centered on treatments for inflammatory pain conditions, including Chemotherapy-Induced Peripheral Neuropathy (CIPN) and endometriosis, as well as heart failure with preserved ejection fraction (HFpEF). Ananda Pharma's approach covers the full development cycle, from identifying clinical potential and optimizing drug candidates to conducting clinical trials and securing marketing authorizations from regulators.

Recent filings

Filing Released Lang Actions
Ananda Developments Plc - Issue of Equity
Share Issue/Capital Change Classification · 100% confidence The document is an announcement regarding the issuance of new ordinary shares following the exercise of warrants. It details the number of shares issued, the price, the purpose of the proceeds, and the updated total share count for the company. This falls directly under the category of share issuance and capital changes.
2021-07-16 English
Ananda Developments Plc - Issue of Convertible Loan Notes
Capital/Financing Update Classification · 100% confidence The document is an announcement regarding the issuance of convertible loan notes (CLNs) by Ananda Developments Plc to raise capital for its subsidiary. It details the terms of the financing, the use of proceeds, and mentions director participation. This falls under the category of company fundraising and financing activities.
2021-07-14 English
Ananda Developments Plc - Notice of Annual General Meeting
AGM Information Classification · 98% confidence The document is a short announcement (under 3,000 characters) informing shareholders that the Notice of the Annual General Meeting has been sent to them. It provides logistical details regarding the meeting's format due to COVID-19 restrictions and instructions for proxy voting and submitting questions. It does not contain the full proxy statement or the meeting materials themselves, but rather serves as a notification of the meeting's occurrence and the distribution of the notice. Therefore, it is classified as a Proxy Solicitation & Information Statement (PSI) as it relates to the solicitation of proxies and the formal notice of the meeting.
2021-07-07 English
Ananda Developments Plc - Issue of Equity
Share Issue/Capital Change Classification · 100% confidence The document is an announcement from Ananda Developments Plc regarding the issuance of new ordinary shares following the exercise of warrants. It details the number of shares issued, the proceeds, and the updated total share count for voting rights calculations. This falls under the category of share issuance and capital changes.
2021-07-06 English
Ananda Developments Plc - Final Results
Audit Report / Information Classification · 95% confidence The document is titled 'Audited Final Results' for Ananda Developments Plc for the year ended 31 January 2021. It contains a business review, a statement of comprehensive income, and a statement of financial position. While it is an announcement of results, it provides the core financial statements and management commentary typical of an annual financial reporting release. Given the length and the inclusion of the full financial tables, it functions as the primary annual financial disclosure for the company, fitting the 10-K (Annual Report) category. FY 2021
2021-07-05 English
Ananda Developments Plc - Shareholder Update
Regulatory Filings Classification · 98% confidence The document is a 'Shareholder Update' issued by Ananda Developments Plc. It provides operational updates regarding the construction of a research facility, the selection of cannabis strains, and a patent update for a subsidiary. It does not constitute a formal financial report (10-K/IR), a proxy statement, or a specific regulatory filing for a meeting. It is a general corporate update released via a Regulatory Information Service (PR Newswire), which falls under the 'Regulatory Filings' category as it provides miscellaneous corporate information that does not fit into more specific categories like M&A or Earnings.
2021-06-25 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.